Education & Training
- Fellowship, Columbia Presbyterian Medical Center, Maternal Fetal Medicine
- Residency, University of Pittsburgh Medical School, Pittsburgh, PA
- MD, West Virigina University School of Medicine, Morgantown, WV
Representative Publications
- Caritis SN, Venkataramanan R. A Pharmacologic Evaluation of Buprenorphine in Pregnancy and the Postpartum Period.Journal of Addiction Medicine. 19(2):129-134, 2025 Mar-Apr 01.
- Caritis SN, Dodeja P, Sharma S, Zhao W, Venkataramanan R. The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant women.American Journal of Obstetrics & Gynecology. 232(1):132.e1-132.e11, 2025 Jan.
- Caritis SN, Costantine MM, Clark S, Stika CS, Kiley JW, Metz TD, Chauhan SP, Venkataramanan R. Relationship between plasma concentration of 17-hydroxyprogesterone caproate and gestational age at preterm delivery.American Journal of Obstetrics & Gynecology MFM. 5(7):100980, 2023 07.
- Caritis SN, Venkataramanan R. Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored. [Review]
For additional publications, please see PubMed Page.
Clinical/Research Interest Summary
Pharmacotherapy during pregnancy, preterm birth, opioid use disorders, diabetes, preeclampsia
Clinical Interests/Research Interests
Dr. Caritis's research focuses on pregnancy complications especially preterm birth and pregnancy pharmacology. He has been the Principal Investigator (PI) on five MFMU Networks and currently the PI for the OPRU Network and Co-PI of the Nullipara Network, as well as the PI on the only T32 in Obstetrical Pharmacology in the United States. Dr. Caritis has been Director of the Maternal-Fetal Medicine Fellowship for 15 years. Our fellowship is one of the largest MFM fellowships in the United States with nine total fellows. Both the department and fellowship are very research focused with the majority of graduating fellows going to academic departments.